BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:04 PM
 | 
Aug 24, 2012
 |  BC Extra  |  Company News

Bristol-Myers to incur $1.8B charge for HCV failure

Bristol-Myers Squibb Co. (NYSE:BMY) said it will incur a $1.8 billion charge this quarter after discontinuing development late Thursday of HCV compound BMS-986094...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >